Published in Neurobiol Aging on September 13, 2008
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis (2011) 2.78
Regulation of AMPA receptor function by the human memory-associated gene KIBRA. Neuron (2011) 2.00
Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry (2009) 1.60
KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. J Biol Chem (2011) 1.50
WWC1 genotype modulates age-related decline in episodic memory function across the adult life span. Biol Psychiatry (2013) 1.43
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis (2010) 1.28
KIBRA protein phosphorylation is regulated by mitotic kinase aurora and protein phosphatase 1. J Biol Chem (2011) 1.14
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12
KIBRA: A New Gateway to Learning and Memory? Front Aging Neurosci (2010) 1.09
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement (2015) 1.03
Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration. Cell Signal (2013) 1.03
KIBRA (KIdney/BRAin protein) regulates learning and memory and stabilizes Protein kinase Mζ. J Neurochem (2013) 0.95
Association of common KIBRA variants with episodic memory and AD risk. Neurobiol Aging (2010) 0.94
AMPAR trafficking in synapse maturation and plasticity. Cell Mol Life Sci (2013) 0.91
A multi-center study of ACE and the risk of late-onset Alzheimer's disease. J Alzheimers Dis (2011) 0.89
Impact of common KIBRA allele on human cognitive functions. Neuropsychopharmacology (2011) 0.88
The role of memory-related gene polymorphisms, KIBRA and CLSTN2, on replicate memory assessment in the elderly. J Neural Transm (Vienna) (2011) 0.88
Cognitive flexibility is associated with KIBRA variant and modulated by recent tobacco use. Neuropsychopharmacology (2009) 0.87
Genetic architecture of declarative memory: implications for complex illnesses. Neuroscientist (2011) 0.85
KIBRA: In the brain and beyond. Cell Signal (2014) 0.85
Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss. Neuron (2016) 0.84
The KIBRA-aPKC connection: A potential regulator of membrane trafficking and cell polarity. Commun Integr Biol (2012) 0.83
Common exonic missense variants in the C2 domain of the human KIBRA protein modify lipid binding and cognitive performance. Transl Psychiatry (2013) 0.79
KIBRA promotes prostate cancer cell proliferation and motility. FEBS J (2016) 0.79
APOE ε4 genotype predicts memory for everyday activities. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2015) 0.78
COMT Val158Met Polymorphism Modulates Cognitive Effects of Dietary Intervention. Front Aging Neurosci (2010) 0.77
Both PKMζ and KIBRA are closely related to reference memory but not working memory in a T-maze task in rats. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2013) 0.77
Impact of KIBRA Polymorphism on Memory Function and the Hippocampus in Older Adults. Neuropsychopharmacology (2015) 0.76
Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk. Schizophr Bull (2015) 0.76
A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients. BMC Med Genomics (2017) 0.75
Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression. Med Sci Monit (2016) 0.75
Single-cell and regional gene expression analysis in Alzheimer's disease. Cell Mol Neurobiol (2012) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci (2005) 12.85
What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc (2002) 9.81
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron (2007) 6.88
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Common Kibra alleles are associated with human memory performance. Science (2006) 3.30
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am J Psychiatry (2002) 3.20
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A (2005) 3.02
Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet (2007) 2.73
Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry (1997) 2.25
Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology (1995) 2.24
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics (2008) 2.11
Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol (2005) 1.97
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics (2006) 1.88
SNiPer-HD: improved genotype calling accuracy by an expectation-maximization algorithm for high-density SNP arrays. Bioinformatics (2006) 1.88
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology (1999) 1.78
Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med (1995) 1.64
KIBRA gene variants are associated with episodic memory in healthy elderly. Neurobiol Aging (2007) 1.46
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol Aging (2005) 1.24
Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk. Neurobiol Aging (2007) 1.23
KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. J Cell Mol Med (2008) 1.17
Failure to replicate effect of Kibra on human memory in two large cohorts of European origin. Am J Med Genet B Neuropsychiatr Genet (2008) 1.11
KIBRA gene variants are associated with episodic memory performance in subjective memory complaints. Neurosci Lett (2008) 1.01
A grading system of Alzheimer disease lesions in neocortical areas. Neurobiol Aging (2003) 0.91
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet (2008) 20.38
International network of cancer genome projects. Nature (2010) 20.35
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature (2006) 11.59
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
A translational profiling approach for the molecular characterization of CNS cell types. Cell (2008) 8.69
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Intra- and interspecific variation in primate gene expression patterns. Science (2002) 7.92
Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proc Natl Acad Sci U S A (2004) 7.70
Identification of genetic variants using bar-coded multiplexed sequencing. Nat Methods (2008) 7.50
A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry (2007) 7.23
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron (2007) 6.88
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol (2007) 5.98
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med (2012) 5.49
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med (2006) 5.28
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature (2011) 4.94
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet (2006) 4.80
Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet (2008) 4.66
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov (2010) 4.55
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med (2009) 4.45
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron (2003) 4.39
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
VPS35 mutations in Parkinson disease. Am J Hum Genet (2011) 4.16